Revolution Medicines Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	217.44	543.06	696.15	161.41	108.5	104.27
Short-Term Investments	1,714	1,746	1,157	483.53	468.56	336.47
Cash & Short-Term Investments	1,932	2,289	1,853	644.94	577.05	440.74
Cash Growth	24.65%	23.55%	187.31%	11.77%	30.93%	259.03%
Receivables	-	-	1.25	4.67	5.93	6.39
Prepaid Expenses	45.98	38.33	25.07	10.57	6.79	6.99
Total Current Assets	1,977	2,328	1,879	660.19	589.77	454.12
Property, Plant & Equipment	167.38	141.82	100.01	73.74	71.24	36.34
Goodwill	14.61	14.61	14.61	14.61	14.61	14.61
Other Intangible Assets	55.87	56.67	57.74	58.81	59.88	60.95
Long-Term Deferred Charges	-	-	-	-	0.5	-
Other Long-Term Assets	36.58	17.57	10.06	4.59	2	1.39
Total Assets	2,252	2,558	2,062	811.93	737.99	567.4
Accounts Payable	74.85	54.43	61.79	21.31	14.06	12.61
Accrued Expenses	146.21	96.03	70.8	28.94	27.41	18.69
Current Portion of Leases	16.33	12.87	7.37	6.77	6.21	3.67
Current Unearned Revenue	-	-	-	4.46	12.36	12.11
Other Current Liabilities	8.24	0.58	3.9	0.51	0.31	0.1
Total Current Liabilities	245.62	163.91	143.85	61.98	60.35	47.18
Long-Term Leases	142.14	122.97	80.58	57.43	60.42	28.99
Long-Term Unearned Revenue	-	-	-	-	6.57	8.48
Long-Term Deferred Tax Liabilities	2.35	2.35	3.12	7.03	7.44	7.44
Other Long-Term Liabilities	8.4	3.86	7.97	0.3	0.63	0.63
Total Liabilities	655.02	293.1	235.51	126.74	135.42	92.73
Common Stock	0.02	0.02	0.02	0.01	0.01	0.01
Additional Paid-In Capital	4,098	4,002	2,963	1,388	1,056	740.1
Retained Earnings	-2,504	-1,738	-1,138	-701.34	-452.64	-265.55
Comprehensive Income & Other	3.12	1.32	0.54	-1.78	-0.38	0.12
Total Common Equity	1,597	2,265	1,826	685.19	602.57	474.68
Shareholders' Equity	1,597	2,265	1,826	685.19	602.57	474.68
Total Liabilities & Equity	2,252	2,558	2,062	811.93	737.99	567.4
Total Debt	414.97	135.84	87.94	64.21	66.63	32.66
Net Cash (Debt)	1,517	2,153	1,765	580.74	510.42	408.08
Net Cash Growth	3.67%	22.01%	203.93%	13.78%	25.08%	232.97%
Net Cash Per Share	8.20	12.84	15.60	7.20	7.01	7.44
Filing Date Shares Outstanding	193.32	185.91	164.69	90.49	74.19	73.38
Total Common Shares Outstanding	189.71	185.9	164.67	90.41	74.14	66.6
Working Capital	1,732	2,164	1,735	598.2	529.42	406.95
Book Value Per Share	8.42	12.19	11.09	7.58	8.13	7.13
Tangible Book Value	1,526	2,194	1,754	611.77	528.08	399.12
Tangible Book Value Per Share	8.05	11.80	10.65	6.77	7.12	5.99
Machinery	37.79	31.44	28.09	21.74	14.98	11.6
Construction In Progress	0.67	0.39	0.51	-	0.13	1.98
Leasehold Improvements	21.49	14.28	11.95	11.4	7.25	3.39

Source: S&P Global Market Intelligence. Standard template. Financial Sources.